v3.25.1
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Cash Flows [Abstract]    
Net earnings $ 117,571 $ 123,234
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Stock-based compensation expense 70,394 63,820
Depreciation 21,729 20,521
Amortization of intangibles 10,478 10,367
Deferred income taxes (3,722) 6,777
Other adjustments, net 5,325 3,585
Changes in assets and liabilities    
Accounts receivable 2,510 71,674
Other assets 15,230 7,118
Accounts payable and other liabilities (49,339) (22,538)
Income taxes payable and receivable 11,525 11,051
Deferred revenue (8,584) (11,506)
Net cash provided by operating activities 193,117 284,103
Cash flows from investing activities:    
Capital expenditures (15,427) (17,234)
Other, net (1,067) (8,814)
Net cash used in investing activities (16,494) (26,048)
Cash flows from financing activities:    
Principal payments on Term Loan (425,000) 0
Proceeds from issuance of common stock pursuant to stock-based awards 378 1,255
Withholding taxes paid on behalf of employees on net settled stock-based awards (78,749) (9,591)
Purchase of treasury stock (188,676) (188,593)
Dividends (47,791) 0
Purchase of noncontrolling interests (84) (737)
Other, net (374) (1,953)
Net cash used in financing activities (740,296) (199,619)
Total cash (used) provided (563,673) 58,436
Effect of exchange rate changes on cash and cash equivalents 7,102 (5,947)
Net (decrease) increase in cash and cash equivalents (556,571) 52,489
Cash and cash equivalents at beginning of period 965,993 862,440
Cash and cash equivalents at end of period $ 409,422 $ 914,929